Should You Think About Buying JD Health International Inc. (HKG:6618) Now?
Jan 07
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies5
- 7D5.7%
- 3M-7.3%
- 1Y3.6%
- YTDn/a
In the last week, the Drug Retail industry is up 4.3%, with JD Health International up 7.6%. However, the industry is down 6.3% over the past year. Looking forward, earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | HK$160.3b | HK$103.4b | HK$3.6b | 38.2x | 44.8x | 1.6x |
| Thu, 19 Dec 2024 | HK$159.4b | HK$103.6b | HK$3.6b | 38.1x | 44.4x | 1.5x |
| Sat, 16 Nov 2024 | HK$170.6b | HK$104.7b | HK$3.6b | 39.1x | 47.1x | 1.6x |
| Mon, 14 Oct 2024 | HK$181.8b | HK$105.4b | HK$3.3b | 52.2x | 54.4x | 1.7x |
| Wed, 11 Sep 2024 | HK$135.7b | HK$105.0b | HK$3.3b | 36.4x | 40.7x | 1.3x |
| Fri, 09 Aug 2024 | HK$137.3b | HK$103.0b | HK$2.4b | 41.4x | 56.9x | 1.3x |
| Sun, 07 Jul 2024 | HK$137.7b | HK$101.9b | HK$2.4b | 41.8x | 57.7x | 1.4x |
| Tue, 04 Jun 2024 | HK$157.7b | HK$102.3b | HK$2.4b | 46.7x | 65.8x | 1.5x |
| Thu, 02 May 2024 | HK$152.9b | HK$103.7b | HK$2.3b | 45.7x | 65.7x | 1.5x |
| Sat, 30 Mar 2024 | HK$158.8b | HK$104.0b | HK$2.3b | 47.9x | 68x | 1.5x |
| Mon, 26 Feb 2024 | HK$175.9b | HK$105.1b | -HK$1,456,103,459.27 | 58.2x | -120.8x | 1.7x |
| Wed, 24 Jan 2024 | HK$162.5b | HK$105.4b | -HK$1,460,866,080.00 | 52.2x | -111.2x | 1.5x |
| Fri, 22 Dec 2023 | HK$203.1b | HK$105.7b | -HK$1,464,003,846.00 | 63.2x | -138.7x | 1.9x |
| Sun, 19 Nov 2023 | HK$211.7b | HK$102.9b | -HK$1,754,792,415.00 | 86.2x | -120.6x | 2.1x |
| Tue, 17 Oct 2023 | HK$224.7b | HK$102.4b | -HK$1,675,089,400.00 | 104.7x | -134.2x | 2.2x |
| Thu, 14 Sep 2023 | HK$230.5b | HK$102.9b | -HK$1,683,528,739.00 | 83x | -136.9x | 2.2x |
| Sat, 12 Aug 2023 | HK$269.5b | HK$95.6b | -HK$4,147,877,661.00 | 124.6x | -65x | 2.8x |
| Mon, 10 Jul 2023 | HK$255.0b | HK$95.8b | -HK$4,157,683,426.00 | 109.3x | -61.3x | 2.7x |
| Wed, 07 Jun 2023 | HK$269.1b | HK$97.1b | -HK$4,293,679,979.00 | 241.8x | -62.7x | 2.8x |
| Fri, 05 May 2023 | HK$299.2b | HK$95.5b | -HK$4,889,151,518.00 | 450.5x | -61.2x | 3.1x |
| Sun, 02 Apr 2023 | HK$317.6b | HK$96.1b | -HK$4,920,288,997.00 | 478.3x | -64.5x | 3.3x |
Price to Earnings Ratio
-120.6x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 43.3x which is lower than its 3-year average PE of 109x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 8.8% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 3.38% | |
| Consumer Staples | 4.52% | |
| Food and Staples Retail | 4.56% | |
| Drug Retail | 5.71% | |
| Food Retail | 2.48% | |
| Big Box Super Stores | 0.77% | |
| Food Distributors | -1.04% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$30.30 | 6.7% +HK$6.1b | 7.4% | PE34.6x | |
| 241 Alibaba Health Information Technology | HK$3.48 | 4.2% +HK$2.3b | 11.2% | PE43.3x | |
| 6086 Fangzhou | HK$2.48 | 18.7% +HK$522.7m | n/a | PS1.3x |
